Sodium Alendronate in Non Surgical Periodontal Therapy
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
In the past few years, studies have evaluated the effect of systemic use of sodium
alendronate, especially in the treatment of structural bone defects caused by periodontal
diseases. This study evaluated the effects of non-surgical periodontal treatment associated
with the topical application of 1% sodium alendronate on clinical and topographical
parameters. Chronic periodontitis patients were recruited for the present study and were
monitored at 3 and 6 months after baseline examinations. A placebo gel was used as control.